Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM)

CUSIP: 14216R101

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
41,966,083
Total 13F shares
8,506,493
Share change
-493,282
Total reported value
$19,308,656
Price per share
$2.27
Number of holders
49
Value change
-$1,165,944
Number of buys
18
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 14216R101?
CUSIP 14216R101 identifies CARM - Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) as of Q1 2024

As of 31 Mar 2024, Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,506,493 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, TPG GP A, LLC, TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and Nuveen Asset Management, LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.